https://doi.org/10.4081/monaldi.2021.1816
The initial experience of COVID-19 vaccination from a tertiary care centre of India
Submitted: February 23, 2021
Accepted: March 19, 2021
Published: March 31, 2021
Accepted: March 19, 2021
Abstract Views: 4494
PDF: 2455
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
To the Editor
Drugs Controller General of India (DCGI) has approved the Bharat biotech vaccine against COVID-19, which is a locally manufactured inactivated vaccine named ''COVAXIN'' in collaboration with the Indian council of medical research (ICMR) on 3rd January 2021 for emergency use along with the "Covishield" Oxford-AstraZeneca vaccine manufactured locally by the Serum Institute of India...
*The Safdarjung COVID-19 Vaccination group:
KR Meena (Professor, Paediatrics), U Venkatesh (Assistant Professor, Community Medicine), Pushpa Kumari (Associate Professor, Medicine), Sonal Burman (Specialist, Medicine), Neeraj Kumar Gupta (Professor and Head, Pulmonary Medicine), Nitesh Gupta (Assistant Professor, Pulmonary Medicine), Rohit Kumar (Assistant Professor, Pulmonary Medicine), Swetabh Purohit (Senior resident, Pulmonary Medicine), Arjun Ramaswamy (Senior resident, Pulmonary Medicine)
Ministry of Health and Family Welfare. Press statement by the Drugs Controller General of India (DCGI) on restricted emergency approval of COVID-19 virus vaccine. Jan 3, 2021. Accessed: January 5, 2021. Available from: https://pib.gov.in/PressReleseDetail.aspx?PRID=1685761
Ella R, Vadrevu KM, Jogdand H, et al. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial. Lancet Infect Dis 2021;21:39-51.
DOI: https://doi.org/10.1016/S1473-3099(20)30831-8
Ella R, Reddy S, Jogdand H, et al. Safety and immunogenicity clinical trial of an inactivated SARS-CoV-2 vaccine, BBV152 (a phase 2, double-blind, randomised controlled trial) and the persistence of immune responses from a phase 1 follow-up report. medRxiv 2020.12.21.20248643.
DOI: https://doi.org/10.1101/2020.12.21.20248643
The Hindu [Internet]. Coronavirus. Covaxin efficacy is 81%, works against variants. Accessed: 18 March 2021. Available from: Downloaded from https://www.thehindu.com/sci-tech/health/bharat-biotech-says-covid-19-vaccine-shows-81-interim-efficacy/article33980224.ece
Government of India. Operational Guideline COVID-19 Vaccines [Internet]. New Delhi; 2021. Accessed: 22 February 2021. Available from: https://www.mohfw.gov.in/pdf/COVID19VaccineOG111Chapter16.pdf
The Times of India [Internet]. Covid-19: India vaccinates 54.7% healthcare workers registered on CoWin platform. Accessed: 22 February 2021. Available from: https://timesofindia.indiatimes.com/india/covid-19-india-vaccinates-54-7-healthcare-workers-registered-on-cowin-platform/articleshow/80725869.cms
WHO. Classification of AEFIS. Accessed: 22 February 2021. Available from: https://vaccine-safety-training.org/classification-of-aefis.html
How to Cite
Srivastava, RK, Pranav Ish, and *Safdarjung COVID-19 Vaccination group. 2021. “The Initial Experience of COVID-19 Vaccination from a Tertiary Care Centre of India”. Monaldi Archives for Chest Disease 91 (4). https://doi.org/10.4081/monaldi.2021.1816.
Copyright (c) 2021 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Laura Bertacchini, Mara Paneroni, Laura Comini, Simonetta Scalvini, Michele Vitacca, Recovering of oxygenation, physical function and disability in patients with Covid-19 , Monaldi Archives for Chest Disease: Vol. 91 No. 4 (2021)
- Mansi Gupta, Pranav Ish, Shibdas Chakrabarti, Manas Kamal Sen, Prabhakar Mishra, Jagdish Chander Suri, Diagnostic accuracy and feasibility of portable sleep monitoring in patients with obstructive sleep apnea: Re-exploring the utility in the current COVID-19 pandemic , Monaldi Archives for Chest Disease: Vol. 92 No. 1 (2022)
- Shreyash Agrawal, Ravindra Nath, Pranav Ish, Neeraj Kumar Gupta, Rajni Gaind, Suniti Kale, Rani Gera, Anjali Dabral, Nitesh Gupta, *Other members of the Safdarjung Hospital COVID 2019 working group, Clinico-epidemiological profile of COVID-19 patients admitted during third wave of pandemic in a tertiary care hospital in New Delhi, India , Monaldi Archives for Chest Disease: Vol. 93 No. 2 (2023)
- Giorgio Ciprandi, Maria Angela Tosca, Non-pharmacological remedies for post-viral acute cough , Monaldi Archives for Chest Disease: Vol. 92 No. 1 (2022)
- Johanna Köhl, Floriana Bardaro, Emanuele Stirpe, An unexpected diagnosis of a lung mass with endobronchial involvement , Monaldi Archives for Chest Disease: Vol. 92 No. 4 (2022)
- Fulvio Cacciapuoti, Erica Vetrano, Federico Cacciapuoti, Left atrial invasion of a lung cancer: a case report , Monaldi Archives for Chest Disease: Vol. 92 No. 3 (2022)
- Aiswarya M Nair, Sowmya Gopalan, Vaasanthi Rajendran, Priyadarshini Varadaraj , Lakshmi Marappa , Viswanathan Pandurangan , Sudha Madhavan, Rajkumar Mani , Emmanuel Bhaskar , Role of secondary sepsis in COVID-19 mortality: Observations on patients with preexisting diabetes mellitus and newly diagnosed hyperglycemia , Monaldi Archives for Chest Disease: Vol. 92 No. 4 (2022)
- Ravindra Nath, Neeraj Kumar Gupta, Amandeep Jaswal, Sparsh Gupta, Navjot Kaur, Santvana Kohli, Anirudh saxena, Pranav Ish, Rohit Kumar, Poornima Tiwari, Mukesh Kumar, Jugal Kishore, Geeta Yadav, Fellisha Marwein, Nitesh Gupta, Mortality among adult hospitalized patients during the first wave and second wave of COVID-19 pandemic at a tertiary care center in India , Monaldi Archives for Chest Disease: Vol. 92 No. 2 (2022)
- Zehra Naseem, Muhammad Mussab Khakwani, Maaha Ayub, Ahmed Ayaz, Bushra Jamil, Ainan Arshad, SARS-CoV-2 induced coagulopathy and potential role of anticoagulation: Scoping review of literature , Monaldi Archives for Chest Disease: Vol. 92 No. 4 (2022)
- Tobin P. Mangel, Brendan P. Madden, Acute tracheal tear – A potential cause of spontaneous pneumomediastinum in patients with COVID-19 , Monaldi Archives for Chest Disease: Vol. 91 No. 2 (2021)
<< < 7 8 9 10 11 12 13 14 > >>
You may also start an advanced similarity search for this article.
